Article Text



Statistics from

Laramée P, Brodtkorb T-H, Rahhali N, et al. The cost-effectiveness and public health benefit of nalmefene added to psychosocial support for the reduction of alcohol consumption in alcoholdependent patients with high/very high drinking risk levels: a Markov model. BMJ Open 2014;4:e005376. The 95% confidence intervals published in the ‘Lower respiratory tract infections’ row of table 9 are incorrect. The correct table 9 is below.

Table 9

Number of patients experiencing modelled harmful events at one year and five years per 100 000 patients for nalmefene plus psychosocial support, psychosocial support alone or patients in the continuous high drinking arm

View Abstract

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles